FDA Gives Green Light to Biogen’s Alzheimer’s Drug

About This Source - Bloomberg Markets and Finance

Bloomberg Markets and Finance features news about financial markets from around the world. Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Bloomberg Books #Ad

Recent from Bloomberg Markets and Finance:

  • Genting’s $4.3 Billion Las Vegas Bet
  • ‘Bloomberg Surveillance’ Full Show (06/24/2021)
  • Apple Daily Doesn’t Represent Press Freedom: LegCo’s IP
  • Bloomberg Markets and Finance published this video item, entitled “FDA Gives Green Light to Biogen’s Alzheimer’s Drug” – below is their description.

    Jun.07 — The FDA approved Biogen’s controversial Alzheimer’s disease therapy, which will be sold under the name Aduhelm. The drug works by removing amyloid, a harmful protein that clogs the brains of Alzheimer’s patients. Bloomberg’s Drew Armstrong reports on “Bloomberg Markets: European Close.”

    Bloomberg Markets and Finance YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment